Antiplatelet therapies are commonly used in neurointerventional procedures. However, specific guidelines for their use in these settings is lacking and it can often be difficult to balance the potential risks and benefits of these medications. Considering the continued growth and adoption of neurointerventional procedures, it is crucial to understand the properties of these agents in order to use them safely. Large-scale clinical trials are still needed to clarify many of these aspects for this emerging field. However, the existing literature already provides insight into which antiplatelet drugs are of benefit to the neurointerventionalist as well as their associated risks of ischemic and hemorrhagic complications. Hence, this review focuses on the applications of GPIIb/IIIA inhibitors to neurointerventional procedures.

抗血小板疗法通常用于神经介入手术。然而，缺乏在这些环境中使用它们的具体指南，而且通常很难平衡这些药物的潜在风险和益处。考虑到神经介入程序的持续增长和采用，了解这些药物的特性以安全使用它们至关重要。仍然需要大规模的临床试验来阐明这一新兴领域的许多方面。然而，现有文献已经提供了关于哪些抗血小板药物对神经介入医师有益以及与缺血和出血并发症相关的风险的见解。因此，本综述重点关注 GPIIb/IIIA 抑制剂在神经介入手术中的应用。